Beijing-based apparel brand bosie has raised a total of 200 million yuan ($30 million) in its Series A+ and B rounds led by Eastern Bell Capital and Genesis Capital, per a company statement on Friday.
GSR Ventures, a $3 billion fund that makes early-stage investments, also participated in the round.
Beijing-headquartered Palm Capital facilitated the transaction.
“The corpus raised will be used for product innovation and launching superstores, said Guangyao Liu, founder at bosie, in a statement.
Bosie, which caters to new generation consumers, is expected to generate 270 million yuan ($41 million) by the end of 2020.
Before the fresh round, Cyanhill Capital and Hangzhou Diedai Capital have together invested ‘millions of US dollars’ in its Series A round in bosie in 2019. Back in 2018, ZhenFund had also invested in its pre Series A round.
CHINA DEAL MONITOR
DealStreetAsia has also put together a table listing out all prominent venture capital transactions in the Greater China region on November 19-20, 2020.
|Startup||Headquarter||Investment Size (USD)||Investment Stage||Lead Investor(s)||Other Investor(s)||Verticals|
|Codemao||Shenzhen||198 million||D||Baring Private Equity Asia (BPEA)||BOC International Holdings, CITIC Securities, Goldstone Investment, Wens Investment, Sino-Ocean Capital, Greater Bay Area Homeland Investments, Youshan Capital, Hillhouse Capital,CMB International, Bohai Zhongsheng, Guangdong Technology Financial Group||EdTech|
|Zeyi Supply Chain||Shanghai||91 million||C||ShenZhen Co-Stone Asset Management, Orchid Asia||CICC Capital||N/A|
|Juventas||Tianjin||69 million||-||CMG-SDIC Capital||Tzitzit Asset, Tianjin Venture Capital, Ruisheng Investment, Xiangrong Capital, Dalton Venture, Parkland Group's investment arm Daxie Pengchuang Investment, Kaixin Biotechnology, Jiadao Fanghua Investment||Biotech|
|Chengdu Weisike Biomedicine||Chengdu||45 million||A||Sichuan Development Holding, Shanghai Pharma||-||HealthTech|
|IntegrityTech||Beijing||30 million||-||Xicheng Jinrui, Beijing Finnacial Street Capital Operation Center||-||Infrastructure|
|bosie||Beijing||30 million||A+, B||Eastern Bell Capital, Genesis Capital||GSR Ventures||Beauty & Hygiene|
|Anke||Shenzhen||15 million||B||Cowin Capital||-||HealthTech|
|Yaohabio||Taizhou||15 million||B||-||Lotus Lake Capital, Shining Capital, CGP Investment||HealthTech|
|Polyv||Guangzhou||15 million||B||Oriza Prior||Aurora Private Equity, HikeCapital||Saas|
|Shenzhen DeepVision Innovation Technology||Shenzhen||* 1.5 million||A||Shenzhen Delin Capital||Chunjian Capital||AI and Machine Learning|
|Jichong Hydrogen Energy Technology||Shanghai||* 1.5 million||Pre-A||Yield Capital||Henan Zhanxin Hydrogen Energy Industry Fund, Yuefeng Jinchuang Investment, Jiangyi Ventures||N/A|
|Idol Group||Shanghai||-||C||Sunshile Insurance Group||Noah Holdings, Sinovation Ventures, Legend Capital||EdTech|
∗ indicates that the company did not provide the specific size of the deal but only a range. So, we adopted the smallest number in the range, which is “10 million yuan ($1.5 million)” in the given example.